ライフサイエンスコーパス: short-chain fatty acid

1 d products that may be used by the host (eg, short-chain fatty acids).

2 is a G protein-coupled receptor activated by short chain fatty acids.

3 S to generate acetate and propionate as main short chain fatty acids.

4 ctional saturated long-chain fatty acids and short-chain fatty acids.

5 including anaerobic fermentation to generate short-chain fatty acids.

6 vation of fatty acid receptors for long- and short-chain fatty acids.

7 tors, two pathways that could be affected by short-chain fatty acids.

8 s, including 5-azacytidine, hydroxyurea, and short-chain fatty acids.

9 s was confirmed by the reduced production of short-chain fatty acids.

10 ng non-mannanolytic populations that produce short-chain fatty acids.

11 ta dysbiosis and increased the production of short-chain fatty acids.

12 sending one-carbon units into production of short-chain fatty acids.

13 acteroidetes, and marked reductions in cecal short-chain fatty acids.

14 high-fiber diet and supplementation with the short-chain fatty acid acetate on the gut microbiota and

15 e impact of a microbiota-derived metabolite, short-chain fatty acid acetate, on an acute mouse model

16 main metabolites of the gut microbiota, the short-chain fatty acid acetate.

17 high-fiber diet or supplementation with the short-chain fatty acid acetate.

18 ntestinal regions by sensing lactate and the short-chain fatty acids acetate and butyrate and then al

19 Levels of the fecal short-chain fatty acids acetate and caproate were reduce

20 The short-chain fatty acids acetate, propionate and butyrate

21 41), are each predominantly activated by the short-chain fatty acids acetate, propionate, and butyrat

22 Fructose and exposure to short-chain fatty acids activate the Ack pathway, involv

23 Short-chain fatty acids affect immune responses and epit

24 Short-chain fatty acids also reduced NF-kappaB activity

25 d long-chain fatty acids exacerbate, whereas short-chain fatty acids ameliorate, autoimmunity in the

26 Also, caecal pH was monitored and short chain fatty acids analysed by gas-liquid chromatog

27 Both short chain fatty acids and C. acnes culture supernatant

28 a, a commensal bacterial genus that produces short chain fatty acids and endotoxins, each of which ma

29 Mass spectrometry measured short chain fatty acids and functional prediction from 1

30 bserved in media containing a combination of short chain fatty acids and glucose and surprisingly, in

31 G protein-coupled receptor that responds to short chain fatty acids and has generated interest as a

32 or 2 in which Gi-mediated signalling by both short chain fatty acids and synthetic agonists was maint

33 on of various fermentation products, such as short-chain fatty acids and alcohol.

34 ch diverse environmental cues (e.g., certain short-chain fatty acids and bile acids) inhibit SPI-1 ex

35 and interleukin-1beta), rebalanced levels of short-chain fatty acids and bile acids, improved gut bar

36 ceramides, and an increased incorporation of short-chain fatty acids and dihydroxylated bases into in

37 at the microbiome, through the production of short-chain fatty acids and in particular, butyrate, is

38 Short-chain fatty acids and lactic acid with 2'-FL were

39 host features that are affected by microbial short-chain fatty acids and other metabolites.

40 Similarly, microbial products such as short-chain fatty acids and sphingolipids also influence

41 one deacetylase (HDAC) inhibitors, including short-chain fatty acids and suberanilohydroxamic acid (S

42 nd redox potential through the production of short-chain fatty acids and that the bacteria adjacent t

43 iota-derived physiological modulators (e.g., short-chain fatty acids) and pathogenic mediators (e.g.,

44 olite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in ho

45 lant cell wall biomass to microbial protein, short chain fatty acids, and gases.

46 ble to identify dysregulation of bile acids, short-chain fatty acids, and cholesterol derivatives tha

47 egrading microbes, produced higher levels of short-chain fatty acids, and drove higher adiposity when

48 of evidence suggest that microbially derived short-chain fatty acids, and particularly butyrate, can

49 f trimethylamine and trimethylamine N-oxide, short-chain fatty acids, and secondary bile acids, that

50 nts of the digestion of lipids consisting of short chain fatty acids are higher than those of lipids

51 Short-chain fatty acids are metabolites generated by int

52 Short-chain fatty acids are processed from indigestible

53 These results identify short-chain fatty acids as a missing link along the gut-

54 rences in microbe-associated amino acids and short-chain fatty acids between APOE genotypes.

55 ission after FMT and had increased levels of short-chain fatty acid biosynthesis and secondary bile a

56 under low- or high-fat feeding, particularly short-chain fatty acids, but not hydrogen sulfide, direc

57 ipase showed the highest specificity towards short-chain fatty acids butanoic and hexanoic acids, the

58 phenylbutyrate (PBA) is a derivative of the short-chain fatty acid butyrate and is approved for trea

59 ation between an increase in the circulating short-chain fatty acid butyrate and pain improvement fol

60 ost epithelium through the production of the short-chain fatty acid butyrate.

61 ut neither AcAc nor the structurally related short-chain fatty acids butyrate and acetate, suppresses

62 ation for increased hepatic IR injury, fecal short-chain fatty acids butyrate and propionate levels w

63 Furthermore, short-chain fatty acids butyrate and propionate protect

64 erium in the human skin microbiome, produces short-chain fatty acids by glycerol fermentation that ca

65 Evidence suggests that short-chain fatty acids can affect the epigenome through

66 acid (VPA), which, like NaB, belongs to the short-chain fatty acid class of HDAC inhibitors, fails t

67 ated amino acids and nicotinate and depleted short chain fatty acids compared to crude fecal control

68 Regarding short-chain fatty acid concentrations, prebiotic adminis

69 re observed in stool frequency or form or in short-chain fatty acid concentrations.

70 ography-mass spectroscopy was used to assess short-chain fatty acid concentrations.

71 myeloperoxidase while decreasing total fecal short-chain fatty acid concentrations.

72 ssociated with significantly decreased cecal short-chain fatty acid concentrations.

73 cronutrient intake, stool diaries, and fecal short-chain fatty acid concentrations.Patients were rand

74 Furthermore, KGM increased cecal short-chain fatty acid contents, and both KGM and inulin

75 he gut microbiota ferment carbohydrates into short-chain fatty acids, convert dietary and endogenous

76 hnospiraceae impact their hosts by producing short-chain fatty acids, converting primary to secondary

77 odelling indicate that Rv2509 belongs to the short-chain fatty acid dehydrogenase/reductase (SDR) fam

78 Short-chain fatty acids derived from gut microbial ferme

79 -28 are required for the biosynthesis of the short-chain fatty acid-derived side chains of the dauer

80 tion pathways for corresponding alcohols and short-chain fatty acids, dissimilatory sulfur oxidation,

81 Here, we demonstrate that short-chain fatty acids, fermentation products of the gu

82 and acetogens may be a significant factor in short chain fatty acid formation in the colon contributi

83 We examined the role of butyric acid, a short-chain fatty acid formed by fermentation in the lar

84 uman acyl-ACP substrate and readily releases short chain fatty acids from full-length FASN during tur

85 disaccharides partially restored total fecal short-chain fatty acids from the level significantly rep

86 at a group of metabolic by-products, namely, short-chain fatty acids, from bacteria that cause period

87 Short-chain fatty acids, generated in colon by bacterial

88 We determined that short-chain fatty acids, gut microbiota-derived bacteria

89 uorobenzyl bromide derivatives of these very short chain fatty acids have high sensitivity of isotopo

90 icrobial and anti-inflammatory activities of short-chain fatty acids have been previously well charac

91 when cultured with butyric acid, a principal short-chain fatty acid in the fermentation metabolites o

92 uch uptake was correlated with appearance of short-chain fatty acids in basal side of the everted sac

93 R43 as essential for the biologic effects of short-chain fatty acids in colon.

94 s microbiota-liberated sugars, hormones, and short-chain fatty acids in regulating pathogenicity.

95 Reduced fecal excretion of short-chain fatty acids (including butyrate, propionate,

96 on of resistant starch leads to increases in short-chain fatty acids, including the clinically benefi

97 volved in the metabolism of carbohydrates to short-chain fatty acids, increases in colonic short-chai

98 ry activity exhibited chemical properties of short chain fatty acids known to be produced from C. acn

99 y in mice, in part through the production of short-chain fatty acids leading to Treg cell development

100 evealed no significant difference in gas and short chain fatty acid level among substrates evaluated.

101 e abundance of Bacteroidetes, elevated fecal short chain fatty acid levels, enrichment of genes assoc

102 Y-FL-pentanoic-acid staining revealed higher short chain fatty acids levels in the intestine of treat

103 hort-chain fatty acids, increases in colonic short-chain fatty acid levels, and alterations in the re

104 crobial organophosphate degradation produces short chain fatty acids like acetic acid, which induces

105 mary effect of HDAC inhibition by endogenous short-chain fatty acids like lactate is to promote gene

106 pendent beta-oxidation of microbiota-derived short-chain fatty acids limits oxygen availability in th

107 ed by gut microbes, increasing production of short chain fatty acids (mainly acetate and lactate) and

108 that supplementation of germ-free mice with short-chain fatty acids, major products of gut bacterial

109 beneficial to the host and demonstrates that short chain fatty acids may be useful to limit formation

110 The metabolites of colon microbiota, e.g. short-chain fatty acids, may influence the brain and beh

111 r 3 (FFA3, previously GPR41) is activated by short-chain fatty acids, mediates health effects of the

112 ociated with EAE susceptibility, implicating short-chain fatty acid metabolism as a key element conse

113 tions included involvement of amino acid and short-chain fatty acid metabolism pathways.

114 0.3 log(10) 16S rRNA gene copies per gram), short-chain fatty acids, microbiome, and ileitis severit

115 ncrease 1.3 +/- 0.5 vs 0.9 +/- 0.6), and the short-chain fatty acids (mumol/g) acetate (decrease 27.4

116 Here, we demonstrate that the short-chain fatty acid n-butyrate, which is secreted in

117 Here, we discuss microbial regulation of short-chain fatty acids, neurotransmitters, as-yet-uncha

118 chicken nutrition through the production of short-chain fatty acids, nitrogen recycling, and amino a

119 A short-chain fatty acid olfactory receptor Olfr78, recent

120 ncreases the interest to elucidate impact of short-chain fatty acids on metabolism, obesity, and the

121 ration of 3-indolepropionic acid, serotonin, short chain fatty acids or tauroursodeoxycholic acid sho

122 Short-chain fatty acids or certain chemotherapeutics hav

123 conferred by bacterial metabolites, such as short-chain fatty acids, or the modulation of immune res

124 to higher ileal and faecal concentrations of short-chain fatty acids (P<0.05).

125 eta cell-expressed GPCR that is activated by short chain fatty acids, particularly acetate.

126 t has esterase activity, with preference for short-chain fatty acids, particularly acetate, with high

127 imethylamine/trimethylamine N-oxide pathway, short-chain fatty acids pathway, and primary and seconda

128 Fatty Acid Receptor 2 is a GPCR activated by short chain fatty acids produced in high levels in the l

129 Butyrate is a short-chain fatty acid produced by the intestinal bacter

130 We show that short-chain fatty acids produced by P. acnes under envir

131 idium-histolyticum groups, and increased the short-chain fatty acids produced compared to the negativ

132 ring diarrhea are considered to be important short-chain fatty acid producers and may be important fo

133 detected and included reduced abundances of short-chain fatty acid-producing bacteria in Canadian HE

134 es identified a significant reduction in the short-chain fatty acid-producing taxonomies Akkermansia,

135 o differences in gut microbiota diversity or short chain fatty acid production across time or with di

136 Short chain fatty acid production during in vitro fermen

137 This could contribute to reduced short chain fatty acid production in IBD.

138 compensatory protective responses, including short chain fatty acid production.

139 Bifidobacterium animalis potentiates colonic short chain fatty acids production and decreases abundan

140 the therapeutic effects of metformin through short-chain fatty acid production, as well as for potent

141 in asymptomatic are enriched in pathways for short-chain fatty acid production.

142 these associations, typified by the role of short-chain fatty acids, products of fibre fermentation

143 The short-chain fatty acid profile contributed by dominant g

144 A decrease in cecal pH and alterations in short chain fatty acid profiles occurred with consumptio

145 lactate, a slightly acidic pH, and specific short-chain fatty acid profiles, which are high in aceta

146 hat dietary fructose- and microbiota-derived short-chain fatty acids promote AckA-mediated acetic aci

147 o parallel pathways for the breakdown of the short chain fatty acid propionate in Caenorhabditis eleg

148 ng the activity of the endogenously produced short chain fatty acid propionate in Gi-mediated pathway

149 tive concentrations of the anti-inflammatory short-chain fatty acids propionate, acetate and butyrate

150 lycylsarcosine), lipid (oleoylethanolamine), short chain fatty acid (propionate) and major rat bile a

151 The addition of the pure short chain fatty acids propionic, isobutyric or isovale

152 ylmethionine (SAM) cycle and breaks down the short-chain fatty acid propionic acid, preventing its to

153 colonic secondary bile acids, lower colonic short-chain fatty acid quantities and higher mucosal pro

154 The short chain fatty acid receptor FFA2 is able to stimulat

155 Analysis of the roles of the short chain fatty acid receptor, free fatty acid 3 recep

156 on node highlighted by the expression of the short-chain fatty acid receptor FFAR3.

157 opulation distinguished by expression of the short-chain fatty acid receptor free fatty acid receptor

158 Depletion of CD25(+) Tregs or absence of the short-chain fatty acid receptor GPR43 abolished this sur

159 Faecal short chain fatty acid (SCFA) and urinary volatile organ

160 erative colitis and sodium butyrate (NaB), a short chain fatty acid (SCFA) normally produced in the i

161 d the intestinal habitat, allowing increased short chain fatty acid (SCFA) production.

162 terial community, stool microRNA (miRNA) and short chain fatty acid (SCFA) signatures to correlate th

163 sociated with an increase in the levels of a short chain fatty acid (SCFA), butyrate.

164 breadth of cellular responses engendered by short chain fatty acid (SCFA)-hexosamine hybrid molecule

165 acidifying the proximal colon and triggering short chain fatty acid (SCFA)-mediated intracellular aci

166 Short chain fatty acids (SCFA) are metabolites of intest

167 , plasma and muscle biochemistry, intestinal short chain fatty acids (SCFA), and liver glycogen of tr

168 ion, freeze-drying caused a relative loss of short chain fatty acids (SCFA).

169 Fermentation end products, in particular the short-chain fatty acid (SCFA) acetate, are believed to b

170 igated the effect of Propionic acid (PPA), a short-chain fatty acid (SCFA) and a product of dys-bioti

171 aturing Gradient Gel Electrophoresis (DGGE), short-chain fatty acid (SCFA) and ammonium analyses were

172 iched diet on gut microbiota composition and short-chain fatty acid (SCFA) concentrations in parallel

173 in cell culture by sodium butyrate (NaB), a short-chain fatty acid (SCFA) histone deacetylase (HDAC)

174 notyping, gut metagenomic sequence and fecal short-chain fatty acid (SCFA) levels were available(2),

175 P < 0.0001), stool frequency (P = 0.02), and short-chain fatty acid (SCFA) producer Lachnospira [fals

176 d comparative analyses of gut microbiota and short-chain fatty acid (SCFA) profiles across different

177 The short-chain fatty acid (SCFA) receptor FFAR3 was found t

178 nockout mice studies implicate the mammalian short-chain fatty acid (SCFA) receptors, FFAR2 and FFAR3

179 Short-chain fatty acid (SCFA) species altered after anti

180 Sodium butyrate (NaBu), a form of short-chain fatty acid (SCFA), acts classically as a pot

181 We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by com

182 s and diversity, depletion of anaerobes, and short-chain fatty acid (SCFA)-producing bacteria, and an

183 f carbohydrates (CHOs) and proteins produces short-chain fatty acids (SCFA) and a range of other meta

184 Short-chain fatty acids (SCFA) are the major anion in st

185 his study evaluated the properties of faecal short-chain fatty acids (SCFA) as diagnostic biomarkers

186 Short-chain fatty acids (SCFA) were measured by HPLC.

187 Short-chain fatty acids (SCFA), formed by microbial ferm

188 We determined that short-chain fatty acids (SCFA), microbiota-derived bacte

189 ts dietary non-digestible carbohydrates into short-chain fatty acids (SCFA).

190 tine, along with lower levels of circulating short-chain fatty acids (SCFA).

191 r without addition of gut metabolites called short-chain fatty acids ([SCFA)] produced during ferment

192 ed ligand selectivity and sensitivity to the short chain fatty acids (SCFAs) acetate and propionate.

193 (rutin) to identify phenolic metabolites and short chain fatty acids (SCFAs) and compare relative ant

194 Short chain fatty acids (SCFAs) are produced in the gut

195 the induction of T regulatory cells, and the short chain fatty acids (SCFAs) butyrate, propionate and

196 cytokines and an increase in IgA levels and short chain fatty acids (SCFAs) in both trachea and lung

197 pecially with no study of gut microbiota and short chain fatty acids (SCFAs) in nephrolithiasis.

198 nd lactobacilli, resulting in high levels of short chain fatty acids (SCFAs) in the cecal material an

199 ticle, we demonstrate that dietary fiber and short chain fatty acids (SCFAs) induced the expression o

200 g bacteria, which ferment dietary fiber into short chain fatty acids (SCFAs) known to be important fo

201 lacking intestinal commensals, which supply short chain fatty acids (SCFAs) such as acetate, also ex

202 Fecal short chain fatty acids (SCFAs) were measured using a li

203 Among the potential mechanisms, short chain fatty acids (SCFAs), the byproducts of micro

204 eceptor expressed in the kidney, responds to short chain fatty acids (SCFAs).

205 Short chain fatty acids (SCFAs; e.g., acetate, propionat

206 3, GPR41) and 2 (FFA2, GPR43), for which the short-chain fatty acids (SCFAs) acetate and propionate a

207 tions in gastrointestinal microbiota-derived short-chain fatty acids (SCFAs) after allogeneic bone ma

208 Microbiota-generated fiber-derived short-chain fatty acids (SCFAs) and free fatty acid rece

209 se metabolism, gut hormones, gut microbiota, short-chain fatty acids (SCFAs) and metabolites.

210 if they can support methane bioconversion to short-chain fatty acids (SCFAs) and the associated micro

211 KEY POINTS: The short-chain fatty acids (SCFAs) are bacterial metabolite

212 The short-chain fatty acids (SCFAs) are bacterial metabolite

213 Short-chain fatty acids (SCFAs) are fermentation end pro

214 Short-chain fatty acids (SCFAs) are fermented dietary co

215 Short-chain fatty acids (SCFAs) are major products of gu

216 Short-chain fatty acids (SCFAs) are metabolites present

217 Short-chain fatty acids (SCFAs) are produced from dietar

218 Short-chain fatty acids (SCFAs) are small molecules ubiq

219 Short-chain fatty acids (SCFAs) are the main products of

220 sobacterium nucleatum produce five different short-chain fatty acids (SCFAs) as metabolic by-products

221 okines (n = 29), fecal calprotectin, and the short-chain fatty acids (SCFAs) butyrate and propionate

222 Short-chain fatty acids (SCFAs) butyrate and propionate

223 weeks of treatment, PLPE increased levels of short-chain fatty acids (SCFAs) by enhancing abundance o

224 of the gut microbiota, and faecal and plasma short-chain fatty acids (SCFAs) determination.

225 Short-chain fatty acids (SCFAs) have immunomodulatory ef

226 Short-chain fatty acids (SCFAs) have protective effects

227 The effects of luminal short-chain fatty acids (SCFAs) in the foregut are unkno

228 e investigated the role of microbial-derived short-chain fatty acids (SCFAs) including acetate, butyr

229 Luminal short-chain fatty acids (SCFAs) influence gut physiologi

230 hods that simulate physiological conditions, short-chain fatty acids (SCFAs) production, and a detail

231 Here, we show that microbiota-derived short-chain fatty acids (SCFAs) promote IL-22 production

232 Short-chain fatty acids (SCFAs) promoted TPH1 transcript

233 lating concentrations of the microbe-derived short-chain fatty acids (SCFAs) propionate and butyrate

234 ns, giving rise to the in situ production of short-chain fatty acids (SCFAs) such as propionic and bu

235 metabolic product of commensal bacteria are short-chain fatty acids (SCFAs) that derive from ferment

236 In the gut, anaerobes produce short-chain fatty acids (SCFAs) that modulate immune and

237 ch as depletion of gut bacteria that produce short-chain fatty acids (SCFAs) through gut fermentation

238 icroArray screen, we demonstrate that excess short-chain fatty acids (SCFAs) trigger replicative cell

239 t enrichment of selective bacteria producing short-chain fatty acids (SCFAs) was tested as a more tar

240 insulin and leptin were determined by ELISA; short-chain fatty acids (SCFAs) were measured in stool s

241 n be fermented by colon microbiota producing short-chain fatty acids (SCFAs) with the ability to prev

242 ABSTRACT: The short-chain fatty acids (SCFAs), acetate, propionate and

243 The short-chain fatty acids (SCFAs), acetate, propionate and

244 absorption, bifidobacteria, total bacteria, short-chain fatty acids (SCFAs), and fecal pH in women w

245 nt capacity, phenolic profile, production of short-chain fatty acids (SCFAs), and gut microbiota comm

246 y GPR43, a receptor for bacterially produced short-chain fatty acids (SCFAs), as a modulator of micro

247 naerobic metabolism, like butyrate and other short-chain fatty acids (SCFAs), induce regulatory T cel

248 ng's mice/wild-type (WT) littermates, mainly short-chain fatty acids (SCFAs), ketones, and alcohols,

249 Here, we tested the hypothesis that short-chain fatty acids (SCFAs), key bioactive microbial

250 Short-chain fatty acids (SCFAs), metabolites produced th

251 We report that short-chain fatty acids (SCFAs), produced by gut microbi

252 plementation of antibiotic-treated mice with short-chain fatty acids (SCFAs), products of microbial m

253 and commensal microbes, such as vitamins and short-chain fatty acids (SCFAs), regulate Treg generatio

254 Microbiota-produced short-chain fatty acids (SCFAs), substrates in the colon

255 Short-chain fatty acids (SCFAs), such as acetate, propio

256 Short-chain fatty acids (SCFAs), such as butyrate, produ

257 particularly decreases in species producing short-chain fatty acids (SCFAs), such as butyrate.

258 Short-chain fatty acids (SCFAs), the most abundant micro

259 Recently, short-chain fatty acids (SCFAs), which are generated by

260 beneficial bacteria in the colon to produce short-chain fatty acids (SCFAs), which are proposed to h

261 fermentation of "indigestible" prebiotics to short-chain fatty acids (SCFAs), which in turn modulate

262 s in rats and in vitro hindgut production of short-chain fatty acids (SCFAs).

263 high concentrations of microbially-produced short-chain fatty acids (SCFAs).

264 ural properties, and capability of producing short-chain fatty acids (SCFAs).

265 LP-1) and peptide YY (PYY) when activated by short-chain fatty acids (SCFAs).

266 ichment increased the fecal concentration of short-chain fatty acids (SCFAs).

267 This study aimed to deliver short-chain fatty acids (SCFAs, including propionic and

268 Short-chain fatty acids (SCFAs; butyrate and propionate)

269 ds/pathways, with specific attention paid to short-chain fatty acids, secondary bile acids, trimethyl

270 We show that short-chain fatty acids selectively increase the number

271 sodium glucose tranporter-1 (SGLT-1) or the short chain fatty acid sensing receptor FFAR2 (GPR43), f

272 1) is a G-protein coupled receptor for which short-chain fatty acids serve as endogenous ligands.

273 ion by 16 S rRNA amplicon sequencing and for short-chain fatty acid (SFCA) analysis.

274 Our study included short-chain fatty acids (sodium butyrate and valproic ac

275 Unlike acetate, short chain fatty acids such as butyrate and propionate

276 nd 65 mug/g, respectively, which, along with short chain fatty acids such as butyric acid (13 mg/g) e

277 D, soluble fiber is the best way to generate short-chain fatty acids such as butyrate, which has anti

278 of germ-free mice with bacteria that produce short-chain fatty acids suppresses cFos expression in th

279 ed with schizophrenia include differences in short-chain fatty acids synthesis, tryptophan metabolism

280 driven with proteins, carbohydrates or other short-chain fatty acids, systems fed with acetic acid re

281 llulosic plant polysaccharides and releasing short chain fatty acids that are then metabolized by the

282 atty acid receptor 2 (FFAR2), a receptor for short-chain fatty acids that can affect the composition

283 PB1 and H. biformis produced short-chain fatty acids that contributed to control prot

284 estingly, all three GDSL enzymes transferred short chain fatty acids to sterols.

285 biome supplies essential metabolites such as short-chain fatty acids to skeletal muscle mitochondria,

286 d, little is known about the contribution of short-chain fatty acids to the adipogenic differentiatio

287 rogenes for which the production of branched short-chain fatty acids was knocked out, we discovered t

288 6 and C18:3n3) from soya bean oil emulsions; short chain fatty acids were released faster than long c

289 s collected from five different time points; short-chain fatty acids were also analyzed in allergic o

290 Concentrations of fecal short-chain fatty acids were determined by using gas chr

291 ns were higher in African Americans, whereas short-chain fatty acids were higher in native Africans.

292 Fecal short-chain fatty acids were measured by gas chromatogra

293 costerone, microbiota composition, and cecal short-chain fatty acids were measured.

294 polyunsaturated fatty acids and formation of short-chain fatty acids were recorded.

295 at plasma levels rather than fecal levels of short-chain fatty acids were relevant to inflammation an

296 enic glutathione complexes, arsenosugars and short chain fatty acids) were also evaluated to assess t

297 d GPR43, is a G-protein coupled receptor for short chain fatty acids which is involved in the mediati

298 r the direct conversion of lignocellulose to short-chain fatty acids, which included the funneling of

299 bundance and translocation of L. reuteri via short-chain fatty acids, which inhibited its growth.

300 tion of valproate (VPA), a widely prescribed short chain fatty acid with anticonvulsant and anticance